Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN112362 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1) antibody
- Antibody type
- Monoclonal
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- MB2
- Vial size
- 0.1 mg
- Storage
- Store lyophilized antibody at -20°C. Following reconstitution the antibody can be stored at 2-8°C for up to two weeks. For longer storage aliquot and store frozen at -20°C to -80°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references 8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells.
Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.
Rong H, Boterberg T, Maubach J, Stove C, Depypere H, Van Slambrouck S, Serreyn R, De Keukeleire D, Mareel M, Bracke M
European journal of cell biology 2001 Sep;80(9):580-5
European journal of cell biology 2001 Sep;80(9):580-5
Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
Steelant WF, Goeman JL, Philippé J, Oomen LC, Hilkens J, Krzewinski-Recchi MA, Huet G, Van der Eycken J, Delannoy P, Bruyneel EA, Mareel MM
International journal of cancer 2001 May 15;92(4):527-36
International journal of cancer 2001 May 15;92(4):527-36
Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro.
Bracke ME, Vyncke BM, Bruyneel EA, Vermeulen SJ, De Bruyne GK, Van Larebeke NA, Vleminckx K, Van Roy FM, Mareel MM
British journal of cancer 1993 Aug;68(2):282-9
British journal of cancer 1993 Aug;68(2):282-9
No comments: Submit comment
No validations: Submit validation data